Question 1

What is Garuda's focus?

Accepted Answer

Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases. Their platform technology aims to generate self-renewing blood stem cells and provide patients with rapid and broad access to consistent, durable, HLA-compatible, and transgene-free blood stem cell therapies.

Question 2

Who are the key leaders at Garuda?

Accepted Answer

Garuda was founded and is supported by experts in blood stem cell and bone marrow transplants, as well as leaders with expertise in bringing transformative medicines to patients. The leadership team includes Avanish Vellanki (CEO), David H. Kirske (CFO), and Panteli Theocharous (Chief Therapeutics Officer and Head of Medical and Scientific Affairs).

Question 3

Who are the members of Garuda's board of directors?

Accepted Answer

The board of directors includes Eric Aguiar (Board Chairperson), Avanish Vellanki (CEO), Adam R. Craig, Carl Gordon, Steve Liapis, Rahul Singhvi, and Laurence Reid.

Question 4

Who are the members of Garuda's scientific advisory board?

Accepted Answer

Garuda's scientific advisory board includes David Scadden (Co-Director, Harvard Stem Cell Institute) and Sean Morrison (Investigator, Howard Hughes Medical Institute and Founder & Director, Children's Research Institute at UT Southwestern).

Voyager DB

Contact Research

People Search

Chrome Extension

Integrations

Garuda Therapeutics

Company Overview

Company Name

Address

Website

Approx. Annual Revenue

Employees

Established

About Garuda Therapeutics

Business Profile

About the website

Biotech & Life Sciences Companies near Cambridge, MA

Frequently Asked Questions about Garuda Therapeutics

What is Garuda's focus?

Who are the key leaders at Garuda?

Who are the members of Garuda's board of directors?

Who are the members of Garuda's scientific advisory board?

Categories

Social Profiles

Key Decision Makers